Membrane transporters in drug development, Nature Reviews Drug Discovery, vol.20, issue.3, pp.215-251, 2010. ,
DOI : 10.1038/nrd3028
The role of hepatic transporters in drug elimination, Expert Opinion on Drug Metabolism & Toxicology, vol.37, issue.4, pp.363-79, 2008. ,
DOI : 10.1080/00498250701570251
A Perspective on Efflux Transport Proteins in the Liver, Clinical Pharmacology & Therapeutics, vol.86, issue.1, pp.599-612, 2012. ,
DOI : 10.1038/clpt.2012.79
Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms, Annual Review of Pharmacology and Toxicology, vol.53, issue.1, pp.581-612, 2013. ,
DOI : 10.1146/annurev-pharmtox-011112-140309
The Role of Transporters in Toxicity and Disease, Drug Metabolism and Disposition, vol.42, issue.4, pp.541-546, 2014. ,
DOI : 10.1124/dmd.114.057539
Drug???Drug Interaction Studies: Regulatory Guidance and An Industry Perspective, The AAPS Journal, vol.15, issue.3, pp.629-674, 2013. ,
DOI : 10.1208/s12248-013-9470-x
Regulation of biliary drug efflux pump expression by hormones and xenobiotics, Toxicology, vol.167, issue.1, pp.37-46, 2001. ,
DOI : 10.1016/S0300-483X(01)00456-5
Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-?? or Interleukin-6, Drug Metabolism and Disposition, vol.37, issue.3, pp.685-93, 2009. ,
DOI : 10.1124/dmd.108.023630
URL : https://hal.archives-ouvertes.fr/hal-00673249
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation, Pharmacological Reviews, vol.62, issue.1, pp.1-96, 2010. ,
DOI : 10.1124/pr.109.002014
Hormonal Regulation of Hepatic Drug Biotransformation and Transport Systems, Compr Physiol, vol.16, issue.Pt 1, pp.1721-1761, 2013. ,
DOI : 10.1002/cphy.c130018
Expression and regulation of hepatic drug and bile acid transporters, Toxicology, vol.153, issue.1-3, pp.203-222, 2000. ,
DOI : 10.1016/S0300-483X(00)00315-2
Regulation of Hepatic Transporters by Xenobiotic Receptors, Current Drug Metabolism, vol.6, issue.4, pp.309-337, 2005. ,
DOI : 10.2174/1389200054633826
Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists, Oncol Res, vol.4, pp.281-90, 1992. ,
Protein kinase C induces endocytosis of the sodium taurocholate cotransporting polypeptide, AJP: Gastrointestinal and Liver Physiology, vol.299, issue.2, pp.320-328, 2010. ,
DOI : 10.1152/ajpgi.00180.2010
Protein kinase C???dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells, Hepatology, vol.34, issue.2, pp.340-50, 2001. ,
DOI : 10.1053/jhep.2001.25959
Novel Mechanism of Impaired Function of Organic Anion-Transporting Polypeptide 1B3 in Human Hepatocytes: Post-Translational Regulation of OATP1B3 by Protein Kinase C Activation, Drug Metabolism and Disposition, vol.42, issue.11, pp.1964-70, 2014. ,
DOI : 10.1124/dmd.114.056945
Ca2+-dependent Protein Kinase C Isoforms Induce Cholestasis in Rat Liver, Journal of Biological Chemistry, vol.279, issue.11, pp.10323-10353, 2004. ,
DOI : 10.1074/jbc.M306242200
Increase in P-glycoprotein accompanied by activation of protein kinase C?? and NF-??B p65 in the livers of rats with streptozotocin-induced diabetes, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1782, issue.5, pp.355-60, 2008. ,
DOI : 10.1016/j.bbadis.2008.02.005
tools to study hepatic drug transporters, Drug Metabolism Reviews, vol.30, issue.2, pp.196-217, 2013. ,
DOI : 10.1091/mbc.E11-01-0047
Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells, Toxicology in Vitro, vol.27, issue.6, pp.1979-86, 2013. ,
DOI : 10.1016/j.tiv.2013.07.003
URL : https://hal.archives-ouvertes.fr/hal-00866007
Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15655-60, 2002. ,
DOI : 10.1073/pnas.232137699
FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES, Drug Metabolism and Disposition, vol.33, issue.10, pp.1418-1440, 2005. ,
DOI : 10.1124/dmd.105.004762
Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes, Toxicology in Vitro, vol.29, issue.5, pp.938-984, 2015. ,
DOI : 10.1016/j.tiv.2015.03.019
URL : https://hal.archives-ouvertes.fr/hal-01141725
Regulation of drug transporter expression by oncostatin M in human hepatocytes, Biochemical Pharmacology, vol.82, issue.3, pp.304-315, 2011. ,
DOI : 10.1016/j.bcp.2011.04.017
URL : https://hal.archives-ouvertes.fr/hal-00680752
Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes, Drug Metabolism and Disposition, vol.37, issue.11, pp.2228-2263, 2009. ,
DOI : 10.1124/dmd.109.028035
URL : https://hal.archives-ouvertes.fr/hal-00673342
Differential Expression of Protein Kinase C Isoform Transcripts in Human Hematopoietic Progenitors Undergoing Differentiation, Biochemical and Biophysical Research Communications, vol.263, issue.3, pp.603-612, 1999. ,
DOI : 10.1006/bbrc.1999.1425
Reversible Ponceau staining as a loading control alternative to actin in Western blots, Analytical biochemistry, vol.401, pp.318-338, 2010. ,
Role of C-Jun and Proximal Phorbol 12-Myristate-13-Acetate-(PMA)-Responsive Elements in the Regulation of Basal and PMA-Stimulated Plasminogen-Activator Inhibitor-1 Gene Expression in HepG2, European Journal of Biochemistry, vol.22, issue.2, pp.393-402, 1996. ,
DOI : 10.1016/0092-8674(91)90241-P
The MARCKS family of cellular protein kinase C substrates, J Biol Chem, vol.268, pp.1501-1505, 1993. ,
Repression of cholesterol 7 alphahydroxylase transcription by bile acids is mediated through protein kinase C in primary cultures of rat hepatocytes, J Lipid Res, vol.36, pp.1359-69, 1995. ,
Ingenol Mebutate Gel for Actinic Keratosis, New England Journal of Medicine, vol.366, issue.11, pp.1010-1019, 2012. ,
DOI : 10.1056/NEJMoa1111170
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC, Blood, vol.106, issue.4, pp.1362-1370, 2005. ,
DOI : 10.1182/blood-2004-10-4117
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C, J Biol Chem, vol.266, pp.15771-81, 1991. ,
G?? 6983 Exerts Cardioprotective Effects in Myocardial Ischemia/Reperfusion, Journal of Cardiovascular Pharmacology, vol.43, issue.5, pp.645-56, 2004. ,
DOI : 10.1097/00005344-200405000-00006
Phorbol ester phorbol-12-myristate-13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cells, The Prostate, vol.1, issue.10, pp.1119-1145, 2010. ,
DOI : 10.1002/pros.21146
The epithelial-mesenchymal transition (EMT) phenomenon, Annals of Oncology, vol.21, issue.Supplement 7, 2010. ,
DOI : 10.1093/annonc/mdq292
URL : https://hal.archives-ouvertes.fr/inserm-00636091
Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype, Veterinary and Comparative Oncology, vol.3, issue.3, pp.169-84, 2013. ,
DOI : 10.1111/j.1476-5829.2011.00313.x
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?, Nature Reviews Cancer, vol.176, issue.6, pp.415-443, 2007. ,
DOI : 10.1038/nrc2131
Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma, Molecular Cancer Therapeutics, vol.10, issue.1, pp.169-77, 2011. ,
DOI : 10.1158/1535-7163.MCT-10-0544
Transforming Growth Factor-beta1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro, Journal of Biological Chemistry, vol.282, issue.30, pp.22089-101, 2007. ,
DOI : 10.1074/jbc.M700998200
HNF4?? Antagonists Discovered by a High-Throughput Screen for Modulators of the Human Insulin Promoter, Chemistry & Biology, vol.19, issue.7, pp.806-824, 2012. ,
DOI : 10.1016/j.chembiol.2012.05.014
The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4??, Hepatology, vol.51, issue.6, pp.2063-74, 2011. ,
DOI : 10.1002/hep.24280
URL : https://hal.archives-ouvertes.fr/pasteur-00980177
Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes, European Journal of Pharmaceutical Sciences, vol.48, issue.4-5, pp.767-74, 2013. ,
DOI : 10.1016/j.ejps.2013.01.005
URL : https://hal.archives-ouvertes.fr/inserm-00804935
-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells, Journal of Biological Chemistry, vol.290, issue.29, pp.17690-709, 2015. ,
DOI : 10.1074/jbc.M115.638510
URL : https://hal.archives-ouvertes.fr/in2p3-00509098
PKC controls HGF-dependent c-Met traffic, signalling and cell migration, The EMBO Journal, vol.21, issue.19, pp.3721-3755, 2004. ,
DOI : 10.1002/jcb.10358
Role of protein kinase C isoforms in bile formation and cholestasis, Hepatology, vol.275, issue.4 ,
DOI : 10.1002/hep.27088
Protein kinase C affects the internalization and recycling of organic anion transporting polypeptide 1B1, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1848, issue.10, pp.2022-2052, 2015. ,
DOI : 10.1016/j.bbamem.2015.05.011
Taurolithocholate-induced MRP2 retrieval involves MARCKS phosphorylation by protein kinase C?? in HUH-NTCP Cells, Hepatology, vol.78, issue.1, pp.284-92, 2013. ,
DOI : 10.1002/hep.26333
Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization, Journal of Biological Chemistry, vol.285, issue.15, pp.11336-11383, 2010. ,
DOI : 10.1074/jbc.M109.056457
Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C, AJP: Gastrointestinal and Liver Physiology, vol.297, issue.3, p.1, 2009. ,
DOI : 10.1152/ajpgi.00052.2009
Optimization of the HepaRG cell model for drug metabolism and toxicity studies, Toxicology in Vitro, vol.26, issue.8, pp.1278-85, 2012. ,
DOI : 10.1016/j.tiv.2012.05.008
URL : https://hal.archives-ouvertes.fr/hal-00866017
tool for understanding drug metabolism and toxicology in human, Expert Opinion on Drug Metabolism & Toxicology, vol.51, issue.5, pp.909-929, 2012. ,
DOI : 10.1016/j.transproceed.2010.08.064
Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay, European Journal of Pharmacology, vol.491, issue.2-3, pp.101-111, 2004. ,
DOI : 10.1016/j.ejphar.2004.03.035
Protein kinase C contains two phorbol ester binding domains, J Biol Chem, vol.266, pp.18330-18338, 1991. ,
Rottlerin, a Novel Protein Kinase Inhibitor, Biochemical and Biophysical Research Communications, vol.199, issue.1, pp.93-101, 1994. ,
DOI : 10.1006/bbrc.1994.1199
Phorbol Ester-induced Apoptosis of C4-2 Cells Requires Both a Unique and a Redundant Protein Kinase C Signaling Pathway, Journal of Biological Chemistry, vol.280, issue.7, pp.5533-5574, 2005. ,
DOI : 10.1074/jbc.M405266200
Epithelial Mesenchymal Transition: a double-edged sword, Clinical and Translational Medicine, vol.11, issue.1, pp.15-0055, 2015. ,
DOI : 10.1186/s40169-015-0055-4
Epithelial-to-mesenchymal transitions in the liver, Hepatology, vol.135, issue.Suppl 1, pp.2007-2020, 2009. ,
DOI : 10.1002/hep.23196
Crosstalk between Beta-Catenin and Snail in the Induction of Epithelial to Mesenchymal Transition in Hepatocarcinoma: Role of the ERK1/2 Pathway, International Journal of Molecular Sciences, vol.14, issue.10, pp.20768-92, 2013. ,
DOI : 10.3390/ijms141020768
Protein kinase C, an elusive therapeutic target?, Nature Reviews Drug Discovery, vol.277, issue.12, pp.937-57, 2012. ,
DOI : 10.1038/nrd3871